Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1128/JCM.01414-21 http://scihub22266oqcxt.onion/10.1128/JCM.01414-21 34346720!8451408!34346720     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Clin+Microbiol 2021 ; 59 (10): e0141421 Nephropedia Template TP {{tp|p=34346720|t=2021. Elevated Rates of Indeterminate Results on QuantiFERON-TB Gold Plus in COVID-19 Patients |pdf=|usr=}}{{34346720}} gab.com Text Elevated Rates of Indeterminate Results on QuantiFERON-TB Gold Plus in COVID-19 Patients JO: J Clin Microbiol http://www.kidney.de/pget.php?&tw=1&pmid=34346720 #FOAvip Interferon gamma release assays are used to screen various patient populations for latent tuberculosis infection. In this issue of the Journal of Clinical Microbiology, J. D. Ward, C. Cornaby, and J. L. Schmitz (J Clin Microbiol 59:e00811-21, 2021, https://doi.org/10.1128/JCM.00811-21) investigated an increased indeterminate rate in the QuantiFERON-TB Gold Plus assay among COVID-19 patients that was independent of immunosuppressive agents and lymphopenia. In their study, COVID-19 patients with indeterminate QuantiFERON-TB Gold Plus results trended toward decreased survival as well as increased serum interleukin-6 (IL-6) and IL-10 levels, although the differences were not statistically significant. They suggest that this pattern of cytokine expression supports an impairment of Th1, specifically interferon gamma production, in critically ill COVID-19 patients, as indicated by indeterminate QuantiFERON-TB Gold Plus results. Clinicians should be aware of the increased rate of indeterminate QuantiFERON-TB Gold Plus results in critically ill COVID-19 patients. Twit Text FOAVip Elevated Rates of Indeterminate Results on QuantiFERON-TB Gold Plus in COVID-19 Patients ????J Clin Microbiol http://www.kidney.de/pget.php?&tw=1&pmid=34346720 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34346720 #FOAvip English Wikipedia <ref>{{Cite pmid|34346720}}</ref> Elevated Rates of Indeterminate Results on QuantiFERON-TB Gold Plus in COVID-19 Patients #MMPMID34346720 Shier KL J Clin Microbiol 2021[Sep]; 59 (10): e0141421 PMID34346720show ga Interferon gamma release assays are used to screen various patient populations for latent tuberculosis infection. In this issue of the Journal of Clinical Microbiology, J. D. Ward, C. Cornaby, and J. L. Schmitz (J Clin Microbiol 59:e00811-21, 2021, https://doi.org/10.1128/JCM.00811-21) investigated an increased indeterminate rate in the QuantiFERON-TB Gold Plus assay among COVID-19 patients that was independent of immunosuppressive agents and lymphopenia. In their study, COVID-19 patients with indeterminate QuantiFERON-TB Gold Plus results trended toward decreased survival as well as increased serum interleukin-6 (IL-6) and IL-10 levels, although the differences were not statistically significant. They suggest that this pattern of cytokine expression supports an impairment of Th1, specifically interferon gamma production, in critically ill COVID-19 patients, as indicated by indeterminate QuantiFERON-TB Gold Plus results. Clinicians should be aware of the increased rate of indeterminate QuantiFERON-TB Gold Plus results in critically ill COVID-19 patients. |*COVID-19[MESH] |*Latent Tuberculosis/diagnosis[MESH] |Humans[MESH] |Interferon-gamma Release Tests[MESH] |Interleukin-10[MESH]Elevated Rates of Indeterminate Results on QuantiFERON-TB Gold Plus in(epmc).pdf DeepDyve Pubget Overpricing